Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II Southwest Oncology Group Study (S0415)

von Gold, Philip J., Goldman, Bryan, Iqbal, Syma, Leichman, Lawrence P., Zhang, Wu, Lenz, Heinz-Josef, Blanke, Charles D.
Veröffentlicht 2010

Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center

von Bitterman, Danielle S., Grew, David, Gu, Ping, Cohen, Richard F., Sanfilippo, Nicholas J., Leichman, Cynthia G., Leichman, Lawrence P., Moore, Harvey G., Gold, Heather T., Du, Kevin L.
Veröffentlicht in J Gastrointest Oncol (2015)

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5‐Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adeno...

von Gibson, Michael K., Catalano, Paul, Kleinberg, Lawrence R., Staley, Charles A., Montgomery, Elizabeth A., Jimeno, Antonio, Song, Wei (Frank), Mulcahy, Mary F., Leichman, Lawrence P., Benson, Al B.
Veröffentlicht in Oncologist (2019)

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarc...

von Leichman, Lawrence P., Goldman, Bryan H., Bohanes, Pierre O., Lenz, Heinz J., Thomas, Charles R., Billingsley, Kevin G., Corless, Christopher L., Iqbal, Syma, Gold, Philip J., Benedetti, Jacqueline K., Danenberg, Kathleen D., Blanke, Charles D.
Veröffentlicht 2011